Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-14

FDA Approved: TERLIVAZ — Original Application (Mallinckrodt Hospital Products Inc.)

View source ↗

Summary

FDA approved TERLIVAZ (terlipressin) from Mallinckrodt Hospital Products Inc. as an original drug application for treatment of adults with hepatorenal syndrome …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TERLIVAZ (terlipressin)

Snippet

ORIG AP for TERLIVAZ (TERLIPRESSIN)